K/S BI BIOMEDICAL VENTURE IV: Financial statements 2012
CVR: 28301022
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
K/S BI BIOMEDICAL VENTURE IV (CVR 28301022) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 28,878,000 and a net result of DKK 28,878,000. Equity in the 2012 report amounted to DKK 161,270,000. The solvency ratio was 100%.
- Gross Profit
- DKK 28,878,000
- Profit/Loss
- DKK 28,878,000
- Equity
- DKK 161,270,000
- Total Assets
- DKK 161,270,000
Official annual report
Keep an eye on K/S BI BIOMEDICAL VENTURE IV
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout K/S BI BIOMEDICAL VENTURE IV
K/S BI BIOMEDICAL VENTURE IV is a Danish company of the type Kommanditselskab based in København K, founded in 2004. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Ahmet Turan Kayhan. The board consists of Andrea Panzieri (chair), Allan Funk Nissen and Ahmet Turan Kayhan. The company is owned by PENSIONSKASSEN FOR TEKNIKUM- OG DIPLOMINGENIØRER and LÆRERNES PENSION, FORSIKRINGSAKTIESELSKAB. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 8,000.
